Keeley-Teton Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,147
Closed -$1.09M 263
2020
Q1
$1.09M Sell
6,147
-150
-2% -$28.2K 0.19% 153
2019
Q4
$1.2M Sell
6,297
-512
-8% -$92.4K 0.13% 168
2019
Q3
$1.15M Hold
6,809
0.12% 177
2019
Q2
$1.14M Hold
6,809
0.11% 183
2019
Q1
$997K Hold
6,809
0.09% 193
2018
Q4
$910K Buy
6,809
+1
+0% +$164 0.09% 193
2018
Q3
$1.3M Hold
6,808
0.09% 184
2018
Q2
$1.14M Buy
6,808
+102
+2% +$16.4K 0.08% 204
2018
Q1
$1.13M Buy
6,706
+1,150
+21% +$193K 0.07% 203
2017
Q4
$909K Buy
+5,556
New +$997K 0.06% 210

Other funds holding AGN

Keeley-Teton Advisors's AGN Position: Q2 2020 in Review

Keeley-Teton Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,147 shares — an estimated $1.09M sold.

Keeley-Teton Advisors first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $1.3M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Keeley-Teton Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Keeley-Teton Advisors sold 6,147 Allergan plc shares in Q2 2020, an estimated $1.09M.
  • Keeley-Teton Advisors first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Keeley-Teton Advisors's Allergan plc position peaked at $1.3M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Keeley-Teton Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.